- Ring The Bell
- Posts
- 🤼‍♂️ Why Tariff Fears Have Rattled The Market Again
🤼‍♂️ Why Tariff Fears Have Rattled The Market Again
Plus, taking a close look at Chinese stocks, and more
You're receiving this email because you're subscribed to Ring the Bell from Benzinga. To manage your subscription, click the link at the bottom of this email.
Happy Tuesday! Trump confirmed that 25% tariffs on Canada and Mexico will proceed as scheduled, raising concerns about supply chain disruptions and inflationary pressures. Here’s what this means for markets — and how investors can prepare for the potential fallout. Also, learn why it’s important to keep focused on China.
—Josh Enomoto
Plus, if you’re looking to invest in the latest biotech innovations, check out today’s sponsor.
MARKET RECAP
Last week: Stocks fell Monday as technology and consumer discretionary sectors led declines, with investors weighing upcoming tariffs on Canada and Mexico. Treasury yields dropped ahead of key inflation data, while markets turned their focus to NVIDIA’s earnings and housing reports for further direction.
On Our Radar: After dissecting the S&P Case-Shiller home price index, analysts will next turn to the consumer confidence report, due in one hour. In the corporate financial arena, Home Depot’s will represent one of the most consequential disclosures.
TOP STORY
Trump confirmed that 25% tariffs on Canada and Mexico will proceed as scheduled, raising concerns about supply chain disruptions and inflationary pressures.
SPONSORED CONTENT
BioLargo (OTC: BLGO) reports delivering “widely successful” results in 2024, marked by growing revenues and zero share dilution. The company reported a string of successes in 2024:
Pooph – BioLargo’s pet odor eliminator sold at major retailers – demonstrated its model’s potential from development to commercialization.
Secured its first commercial PFAS treatment project.
Advanced the development of its Bioclynse wound irrigation solution.
Took significant steps forward in creating its liquid-sodium battery technology.
Looking ahead to 2025, the company aims to uplist to the Nasdaq or the NYSE while expanding its commercial presence and continuing historical revenue growth performance.
“This past year was transformative for our company and was a testament to our evolution as a cleantech innovator and solutions provider," said President and CEO Dennis P. Calvert.
This is a paid ad. Please see 17b disclosure here for more information.
FIVE ZINGERS
Online Cart: Cathie Wood's Ark Invest raised eyebrows with a significant purchase of Amazon shares. Read about what could be driving this decision.
Energy Rush: Hydrocarbon specialist Diamondback Energy posted its Q4 results, disclosing $3.71 billion in revenue and beating analysts' consensus target. Learn about the other key metrics here.
Cold Water: High-flying healthcare specialist Tempus AI posted Q4 revenue of $200.68 million, missing the consensus view of $203.12 million. Discover how management is framing the company's results.
Losing Air: Hims & Hers Health reported its Q4 results after Monday's closing bell, beating on sales and meeting earnings expectations. However, HIMS stock suffered a sizable drop during after-hours trading.
Big Miss: Online tutoring platform Chegg beat analysts' target for revenue but the top line fell sharply from the prior year. Here's how management aims to stay competitive.
SPECIAL OFFER
Editor’s Note: Every week, Benzinga Edge members receive the Insider Report. It’s a rundown of what to expect from the markets in the week to come, which sectors are outperforming and why, and most importantly, a selection of hand-picked stocks that are poised to move up because of that week’s trends. Here’s a sneak peek:
I've been hammering home the China theme over the past few weeks, and I'm not going to stop until the magnitude of the situation is fully grasped. Historically, the Chinese market tends to exhibit tremendous rallies once it gets going, so it's key to pay attention at the right moments.
This week, we're comparing the performance of large-cap Chinese stocks (FXI) against a basket of European equities (VGK). We already established how Chinese stocks were outperforming U.S. stocks, but it's worth noting that European stocks have outperformed U.S. stocks year-to-date too.
The ratio here displays a rounding bottom formation, and if it clears the upper horizontal trendline acting as resistance, expect the headlines coming from China to reach a level of bullishness we've not seen in many years.
To keep reading and to find out how investors can get in front of the noise, sign up for the Insider Report here.
SPECIAL OFFER
Learn how to identify deeply undervalued stocks, track insider buying trends and craft a market-resilient portfolio with Tim Melvin and Ryan Faloona. Join them on Tuesday, February 25, at 6 PM ET for a full look into their actionable investing strategies. Don’t miss out—register now!
BEFORE YOU GO
Were you forwarded this email? Click here to subscribe.
And be sure to check out our other newsletters:
Future Finance: Where fintech, crypto and the future of finance collide. Future Finance is a perfect lunch read packed with quick bites for industry enthusiasts. Subscribe here.
Cannabis Daily: A must-read daily briefing for cannabis investors, operators and enthusiasts. Join our list of industry veterans to jump start your morning. Subscribe here.
Real Estate Weekly: Ready to elevate your real estate game? This weekly newsletter provides actionable insights whether you are investing in REITs, owning property or delving into the fast-growing world of fractional real estate. Subscribe here.
Advisor: Tailor-made for Financial Advisors, this weekly newsletter has industry-specific insights, analysis, and news. Subscribe here.
Tech Trends: Get the inside scoop on AI, the hottest gadgets and mind-blowing tech trends. Subscribe here.